The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
about
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.TRPV1 channels mediate long-term depression at synapses on hippocampal interneuronsEmerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammationEffects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1)Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptorCharacterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assayAnandamide and vanilloid TRPV1 receptorsTreatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretionHarm reduction--the cannabis paradoxCapsaicin, Nociception and PainTRPV1 and SP: key elements for sepsis outcome?Amygdala FAAH and anandamide: mediating protection and recovery from stressPharmacological differences between the human and rat vanilloid receptor 1 (VR1)Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamideOptical control of TRPV1 channelsInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamideAnandamide activates peripheral nociceptors in normal and arthritic rat knee jointsStructure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferensA possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchusDifferential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptorsThe effects of pH on the interaction between capsaicin and the vanilloid receptor in rat dorsal root ganglia neuronsCannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neuronesThe endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airwaysThe endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1.Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized ratEffect of vanilloid drugs on gastrointestinal transit in miceMolecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideAnandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channelsDirect inhibition of T-type calcium channels by the endogenous cannabinoid anandamideDevelopmental regulation of fear learning and anxiety behavior by endocannabinoids.Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG).Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.Positive allosteric modulation of TRPV1 as a novel analgesic mechanism.Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytesThe genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized miceInhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells.Capsaicin-induced changes in LTP in the lateral amygdala are mediated by TRPV1.
P2860
Q24534526-823A44E4-FD10-46DD-B34F-F355CBFF5FC2Q24630453-6E95FF9D-5CFC-42F8-8718-26F64E4749D6Q24644177-ABD0737B-926B-4DC3-AB8C-6D145D3E6634Q24647850-AEAD2A03-FB39-4F13-9E8D-1723C9F5E898Q24670592-565E9180-79D8-4173-8331-B5FD29F5793AQ24671838-68BBE12A-98E1-4E09-A3A6-16F173C18E9DQ24672180-28095D8B-FDB9-4E59-963B-04EE93F94269Q24672354-664071E2-2B40-4576-8E43-36C7CD4835A8Q24800293-7F92E05F-27A3-4526-9FB6-31C3A56685FCQ24814542-6C275123-F18B-40C8-8544-1F39094F9574Q26744369-A080ECB8-3C7E-4AA1-816E-E7F37B085675Q27015036-DE1A279F-1DC4-4184-AEC3-12B032733844Q27026443-E026CB46-F4FC-4C55-BA0A-5AB7372CB52DQ28115814-C53BE236-5A55-4001-A8D5-FBEC2C09D189Q28248981-2A79C640-A23A-4E4D-BE57-E703ECCA421FQ28294957-D7B9D529-70E1-4D6F-AA33-E7F6EF14ED3BQ28298445-843A3BD1-7996-4640-9241-4E9740500FF6Q28345160-33EA7663-81DB-446B-810B-835839DE7CF3Q28346449-A8201B47-4B1E-489C-9BC3-1950CC1E671BQ28346456-7790CC68-95A2-412C-A2C8-078A2F1FC585Q28346701-09A7A5FC-8BB8-464F-92FF-A7754A32BB99Q28346747-9183E187-73B9-45F5-9B60-9B4866A2101FQ28349884-4AD23AFD-D760-4380-8890-8C7BEB738DDCQ28354137-6FC10C08-047F-4D4F-AE07-4B72FC177AABQ28354238-BC142F8B-7626-46CF-9CBF-EE4C784D0904Q28354250-7870F5C2-2FAF-4B9D-89FC-DF4AF000172BQ28361093-234B1F97-8339-4B20-9CA5-4AABE7373185Q28361178-B31BC5C9-B2A4-4625-AB01-D806759E7CD6Q28362078-FB0C6744-7F4C-4F31-B17D-58FEDF6555C4Q28362724-9646E4A0-6430-46A8-820C-75913D2F7BDAQ28366316-51C280F8-5CB3-4E99-A9F2-CC9A3D487F9EQ30366747-6201F05B-4471-4969-842E-15B595EECF6AQ30484392-A8405C34-D2BC-429E-88FD-68C053C53122Q30517938-61DC3077-673C-432C-B784-B0DBD8F509A7Q31099124-FE3AD359-1D60-477F-841A-36E6DACE7FFEQ31522100-E43B39B4-5745-4BD0-B0FC-25876D7DC524Q33317863-58316714-8139-465B-BB92-9296F85C4470Q33562189-4E4A0925-72A6-4538-86AB-0166EB9FDDDAQ33674608-C0152C51-3A4E-481F-A7AF-C33D02D01BC5Q33797910-0AB0BE00-2C20-4D08-B4B3-A85C85B87123
P2860
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@ast
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@en
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@nl
type
label
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@ast
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@en
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@nl
prefLabel
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@ast
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@en
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@nl
P2093
P2860
P3181
P356
P1476
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
@en
P2093
J C Jerman
J K Chambers
M J Gunthorpe
P2860
P304
P3181
P356
10.1038/SJ.BJP.0703050
P407
P577
2000-01-01T00:00:00Z